Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Angle to Comarket Liquid Biopsy Technologies

NEW YORK (GenomeWeb) – UK-based liquid biopsy firm Angle said today that it has inked a comarketing agreement with Qiagen for circulating tumor cell (CTC) technology.

Under the terms of the agreement, the companies will market Angle's Parsortix system for harvesting CTCs alongside Qiagen's liquid biopsy product portfolio, including its next-generation sequencing, PCR, single-cell analysis, and bioinformatics products.

The companies will initially focus on prostate and breast cancer research applications, Angle said.

Angle's Parsortix system automates the processing of whole blood to harvest all types of CTCs, including clinically relevant mesenchymal CTCs, and complements Qiagen's AdnaTest CTC portfolio, enabling phenotypic and molecular characterization of CTCs, Michael Kazinski, senior director of molecular preanalytic technologies at Qiagen, said in a statement.

"We believe the ability to offer customers a combination of Parsortix with validated and reliable downstream analysis technologies from … Qiagen facilitates key aspects of the sales cycle and we look forward to working closely together," Angle Founder and CEO Andrew Newland added.

The Scan

Hormone-Based Gene Therapy to Sterilize Domestic Cat

A new paper in Nature Communication suggests that gene therapy could be a safer alternative to spaying domestic cats.

Active Lifestyle Linked to Type 2 Diabetes Prevention in People at High Genetic Risk

A study in the British Journal of Sports Medicine shows that an active lifestyle goes a long way in type 2 diabetes prevention.

Beneficial, Harmful Effects of Introgression Between Wild and Domesticated European Grapes

A paper in PNAS shows that European wild grapevines were an important resource for improving the flavor of cultivated wine grapes.

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.